Article Information
- Received March 26, 2023
- Revision received July 26, 2023
- Accepted July 28, 2023
- Published online September 14, 2023.
Author Information
- Agata Idziak1,
- V. V. G. Krishna Inavalli1,
- Stéphane Bancelin1,
- Misa Arizono1,2 and
- U. Valentin Nägerl1
- 1Unité Mixte de Recherche 5297, Interdisciplinary Institute for Neuroscience, Centre National de la Recherche Scientifique, University of Bordeaux, Bordeaux F-33000, France
- 2Department of Pharmacology, Kyoto University Graduate School of Medicine/The Hakubi Center for Advanced Research, Kyoto University, Kyoto 606-8501, Japan
- Correspondence should be addressed to Misa Arizono at arizono.misa.7s{at}kyoto-u.ac.jp or U. Valentin Nägerl at valentin.nagerl{at}u-bordeaux.fr.
Author contributions
Author contributions: A.I. performed research; A.I. analyzed data; A.I., M.A., and U.V.N. wrote the paper; V.V.G.K.I. and S.B. contributed unpublished reagents/analytic tools; M.A. and U.V.N. designed research.
Disclosures
The authors declare no competing financial interests.
This work was supported by ANR (Agence Nationale de la Recherche) Grants ERA NET NEURON, ANR-17-NEU3-0005, and ANR-17-CE37-0011 (to U.V.N.), Fondation pour la Recherche Médicale, the Human Frontier Science Program Grant RGP0041/2019, the European Research Council Synergy Grant ENSEMBLE, #951294 (to U.V.N.), and a PhD fellowship from Bordeaux Neurocampus Graduate Program (A.I.). S.B. received funding from Horizon 2020 program under the Marie Sklodowska-Curie Grant 794492 as well as from the Fonds AXA pour la Recherche, AXA Banque Direction Banque Patrimoniale et Ses Donateurs. M.A. received funding from Japan Society for the Promotion of Science (JSPS).
Funding
EC | ERC | HORIZON EUROPE European Research Council (ERC)
ENSEMBLE; #951294Agence Nationale de la Recherche (ANR)
ANR-17-NEU3-0005; ANR-17-CE37-0011Human Frontier Science Program (HFSP)
RGP0041/2019
Other Version
- You are viewing the most recent version of this article.
- previous version (September 14, 2023).